Get notified when ARTL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Arbitration Claim Omitted From Original Filing (new) — Company filed amendment to add arbitration disclosure eight days after original 10-Q stated no material litigation, suggesting potential materiality of the claim.
NASDAQ: ARTL ARTELO BIOSCIENCES, INC. 10-Q/A

Artelo amends Q2 10-Q to disclose previously omitted arbitration claim

Filed August 20, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 12, 2026 · ~1 min read

Key Financials

SEC XBRL

Period financials are unchanged from the original 10-Q (same period end Jun 30, 2026). This amendment updates disclosure only — see the diff below.

Key Changes

  • high

    Company filed amendment eight days after original Q2 10-Q to add arbitration claim disclosure that was inadvertently omitted. Original filing stated no material legal proceedings; that statement removed in amendment.

    Legal Proceedings verify on EDGAR →
  • medium

    Amendment limited to arbitration disclosure and required officer certifications; no changes to Q2 financial results or other disclosures from original August 12 filing.

    Amendment scope view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ATLN 10-Q) is open in full — no account needed.

Partner

Trade ARTL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 21, 2026 · How we verify